Table 2. Main symptoms at diagnosis, patient management, and respiratory support in cystic fibrosis patients with COVID-19.
| Variable | n (%) |
|---|---|
| Symptoms at diagnosis | |
| Fever | 8 (47) |
| Dyspnea | 9 (53) |
| Cough | 10 (59) |
| Increased sputum volume | 7 (41) |
| Fatigue and/or asthenia | 9 (53) |
| Headache | 4 (23.5) |
| Myalgia and/or arthralgia | 4 (23.5) |
| Ageusia and/or anosmia | 4 (23.5) |
| Hemoptysis | 1 (5.8) |
| Nausea, vomiting, and/or diarrhea | 4 (23.5) |
| Patient management | |
| Outpatient care | 11 (64.7) |
| Hospitalization | 6 (35) |
| Medical ward | 5 (83) |
| ICU | 1 (16) |
| Respiratory support | |
| Additional oxygen therapy | 3 (17.6) |
| Noninvasive ventilation | 1 (5.8) |
| High-flow nasal cannula oxygen therapy | 0 |
| Invasive ventilation | 1 (5.8) |
| ECMO | 0 |
ECMO: extracorporeal membrane oxygenation.